Cargando…

Anti-programmed cell death protein 1 (anti-PD1) immunotherapy induced autoimmune polyendocrine syndrome type II (APS-2): a case report and review of the literature

BACKGROUND: Autoimmune polyendocrine syndrome type II (APS-2) is a rare constellation of autoimmune hypoadrenalism, thyroid dysfunction and/or type 1 diabetes (T1DM), usually occurring in the 3rd or 4th decades and associated with a human leukocyte antigen (HLA) DR3 or DR4 serotype. We detail the fi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gunjur, Ashray, Klein, Oliver, Kee, Damien, Cebon, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6729071/ https://www.ncbi.nlm.nih.gov/pubmed/31488221 http://dx.doi.org/10.1186/s40425-019-0713-y

Ejemplares similares

Immune Checkpoint Blockade Anti–PD-L1 as a Trigger for Autoimmune Polyendocrine Syndrome
por: Lanzolla, Giulia, et al.
Publicado: (2019)

Adolescent Anxiety or Polyendocrine Autoimmunity?
por: Smith, Whitney N., et al.
Publicado: (2020)

Oral microbiota in autoimmune polyendocrine syndrome type 1
por: Bruserud, Øyvind, et al.
Publicado: (2018)

Precipitation of Autoimmune Diabetes With Anti-PD-1 Immunotherapy
por: Hughes, Jing, et al.
Publicado: (2015)

Autoimmune polyendocrine syndrome type 4 with systemic lupus erythematosus and anti-phospholipid syndrome
por: Wang, Yu, et al.
Publicado: (2020)

Autoimmune Polyendocrine Syndromes in the Pediatric Age
por: Paparella, Roberto, et al.
Publicado: (2023)

A rare combination of type 3 autoimmune polyendocrine syndrome (APS-3) or multiple autoimmune syndrome (MAS-3)
por: Betterle, Corrado, et al.
Publicado: (2014)

Oral Tongue Malignancies in Autoimmune Polyendocrine Syndrome Type 1
por: Bruserud, Øyvind, et al.
Publicado: (2018)

Chronic Mucocutaneous Candidiasis in Autoimmune Polyendocrine Syndrome Type 1
por: Humbert, Linda, et al.
Publicado: (2018)

Autoimmune polyendocrine syndromes associated with autoimmune rheumatic diseases
por: Jankowska, Katarzyna, et al.
Publicado: (2023)

A Longitudinal Follow-up of Autoimmune Polyendocrine Syndrome Type 1
por: Bruserud, Øyvind, et al.
Publicado: (2016)

Autoimmune polyendocrine syndrome type 1: an Italian survey on 158 patients
por: Garelli, S., et al.
Publicado: (2021)

Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1
por: Landegren, Nils, et al.
Publicado: (2016)

Shock: A possible presenting manifestation of autoimmune polyendocrine syndrome type II
por: Banzal, Subodh, et al.
Publicado: (2014)

Mixed phenotypic presentation of autoimmune polyendocrine syndrome type II in adolescent female
por: Kumar, Sandip, et al.
Publicado: (2020)

Autoimmunity and cystatin SA 1 deficiency behind chronic mucocutaneous candidiasis in autoimmune polyendocrine syndrome
por: Lindh, Emma, et al.
Publicado: (2012)

Autoimmune polyendocrine syndrome type 1 in an Indian cohort: a longitudinal study
por: Zaidi, Ghazala, et al.
Publicado: (2017)

A novel AIRE mutation leads to autoimmune polyendocrine syndrome type-1
por: Qian, Guofeng, et al.
Publicado: (2022)

Case of autoimmune polyendocrine syndrome type 3 complicated with anti‐N‐methyl‐D‐aspartic acid‐receptor encephalitis
por: Kurozumi, Akira, et al.
Publicado: (2020)

Co-Occurrence of Systemic Lupus Erythematosus and Autoimmune Polyendocrine Syndrome II: Is There a Pathologic Link?
por: Aamer, Sameen, et al.
Publicado: (2020)

Updated efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in metastatic melanoma patients previously treated with anti-PD-1 therapy
por: Prithviraj, Prashanth, et al.
Publicado: (2015)

New Splice Site Acceptor Mutation in AIRE Gene in Autoimmune Polyendocrine Syndrome Type 1
por: Mora, Mireia, et al.
Publicado: (2014)

Late-onset autoimmune polyendocrine syndrome type 1: a case report and literature review
por: Zhan, Feixia, et al.
Publicado: (2021)

Patients with autoimmune polyendocrine syndrome type 1 have an increased susceptibility to severe herpesvirus infections
por: Hetemäki, Iivo, et al.
Publicado: (2021)

Characterization of the clinical and genetic spectrum of autoimmune polyendocrine syndrome type 1 in Chinese case series
por: Wang, Ya-Bing, et al.
Publicado: (2021)

PMON317 Rapid Progression of Adrenal insufficiency in Child with Autoimmune Polyendocrine Syndrome Type 1
por: Umscheid, Jacob, et al.
Publicado: (2022)

Autoimmune polyendocrine syndrome II presenting paradoxically as Takotsubo cardiomyopathy: a case report and reappraisal of pathophysiology
por: Batta, Akash, et al.
Publicado: (2022)

Search for Genetic Predictors of Adult Autoimmune Polyendocrine Syndrome in Monozygotic Twins
por: Yukina, Marina Yuryevna, et al.
Publicado: (2021)

Hypothalamic–Pituitary Autoimmunity in Patients Treated with Anti-PD-1 and Anti-PD-L1 Antibodies
por: Bellastella, Giuseppe, et al.
Publicado: (2021)

Diverse cutaneous adverse eruptions caused by anti-programmed cell death-1 (PD-1) and anti-programmed cell death ligand-1 (PD-L1) immunotherapies: clinical features and management
por: Shen, John, et al.
Publicado: (2018)

A Functional Alternative Splicing Mutation in AIRE Gene Causes Autoimmune Polyendocrine Syndrome Type 1
por: Zhang, Junyu, et al.
Publicado: (2013)

Alopecia Areata Universalis in the Onset of Autoimmune Polyendocrine Syndrome Type III C
por: Neagu, Nicoleta, et al.
Publicado: (2022)

FRI258 A Diagnostic Journey To Autoimmune Polyendocrine Syndrome Type 2
por: Amankwah, Samuel, et al.
Publicado: (2023)

Neoadjuvant anti-PD-1 immunotherapy for recurrent glioblastoma
por: Mitchell, Dana, et al.
Publicado: (2019)

Inefficiencies in phase II to phase III transition impeding successful drug development in glioblastoma
por: Balasubramanian, Adithya, et al.
Publicado: (2020)

Cutaneous vasculitis in patients with autoimmune polyendocrine syndrome type 1: report of a case and brief review of the literature
por: Improda, Nicola, et al.
Publicado: (2014)

Altered Immune Activation and IL-23 Signaling in Response to Candida albicans in Autoimmune Polyendocrine Syndrome Type 1
por: Bruserud, Øyvind, et al.
Publicado: (2017)

A novel variant in AIRE causing a rare, non-classical autoimmune polyendocrine syndrome type 1
por: Zheng, Wen-Bin, et al.
Publicado: (2020)

A novel compound heterozygous mutation of the AIRE gene in a patient with autoimmune polyendocrine syndrome type 1
por: Suh, Junghwan, et al.
Publicado: (2019)

A partial form of AIRE deficiency underlies a mild form of autoimmune polyendocrine syndrome type 1
por: Oftedal, Bergithe Eikeland, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3fss4sjgkvr6ajkf2vm328aipr